
    
      A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study
      to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple
      Ascending Inhaled Doses of AZD2115 in Healthy Male Subjects.
    
  